Cytokinetics PT receives Investment Bank Analyst Rating Update
- ByInvesting.com-
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Cytokinetics Inc (CYTK)
NASDAQ
Symbol | Exchange | Currency |
|---|
50.14
-0.16(-0.32%)
- Volume:123,868
- Day's Range:49.32 - 50.55
- 52 wk Range:29.10 - 54.74
CYTK Overview
- Prev. Close
- 50.3
- Day's Range
- 49.32-50.55
- Revenue
- 151.15M
- Open
- 50.28
- 52 wk Range
- 29.1-54.74
- EPS
- -2.58
- Volume
- 123,868
- Market Cap
- 4.68B
- Dividend (Yield)
- N/A(N/A)
- Average Vol. (3m)
- 1,379,621
- P/E Ratio
- -
- Beta
- 1.14
- 1-Year Change
- 56.45%
- Shares Outstanding
- 94,144,097
- Next Earnings Date
- Nov 03, 2022
What is your sentiment on Cytokinetics Inc?
or
Vote to see community's results!
Cytokinetics Inc Analysis
- A Few New Stocks That Show Continuing Verve
In this tiresome up-every-day market, here are some relatively new stocks that continue to show verve. Of course, high-fliers in a richly-valued market are still...
- 6 Stocks That Could Pop Higher
1. BioCrystBioCryst Pharmaceuticals (NASDAQ:BCRX), in the biotech vaccine area, on Tuesday popped to 5.41, up 46 cents, or 9%, after reaching a midday high of 5.56, on 10.9...
- 6 Stock Charts To Watch: AMRS, CYTK, DRNA, LX, MRNA, VAPO
1. Amyris (NASDAQ:AMRS) popped on Monday with good volume, gaining 81 cents, or 30%, to 3.49, after reaching a session high of 3.70, on 6.4 million shares traded. It broke out...
Cytokinetics Inc Company Profile
Cytokinetics Inc Company Profile
Cytokinetics, Incorporated is a late-stage biopharmaceutical company. It is focused on discovering, developing, and commercializing muscle activators and muscle inhibitors as potential treatments for debilitating diseases. It is developing small molecule drug candidates specifically engineered to impact muscle function and contractility. Its clinical-stage drug candidates are: omecamtiv mecarbil, a cardiac myosin activator for the treatment of heart failure with reduced ejection fraction (HFrEF); CK-136, a cardiac troponin activator for the treatment of heart failure and other diseases; reldesemtiv (CK-2127107), a fast skeletal muscle troponin activator (FSTA) for the treatment of people living with debilitating diseases and conditions associated with muscular weakness; aficamten (CK-274), a cardiac myosin inhibitor designed to reduce the hypercontractility that is associated with hypertrophic cardiomyopathy (HCM); and CK-3772271 (CK-271), a second novel cardiac myosin inhibitor.
Read More
Technical Summary
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Neutral | Neutral | Sell | Buy | Strong Buy |
| Technical Indicators | Sell | Buy | Neutral | Strong Buy | Strong Buy |
| Summary | Neutral | Neutral | Neutral | Strong Buy | Strong Buy |
Trending Stocks
Trending Stocks
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 49.47 | 50.06 | 49.40 | -0.64 | -1.29% | 5.12M | NYSE | |||
| 580.52 | 586.22 | 573.57 | +0.64 | +0.11% | 70.52K | NYSE | |||
| 122.56 | 123.13 | 121.57 | -0.10 | -0.08% | 5.04M | NASDAQ | |||
| 31.43 | 31.55 | 30.71 | -1.32 | -4.02% | 3.50M | NYSE | |||
| 3.54 | 3.54 | 3.47 | -0.060 | -1.67% | 5.80M | NYSE | |||
| 1.1611 | 1.19 | 1.15 | -0.0489 | -4.04% | 1.50M | NYSE | |||
| 8.06 | 8.09 | 7.85 | -0.30 | -3.57% | 2.89M | NYSE | |||
| 45.30 | 45.38 | 44.78 | -0.96 | -2.08% | 962.11K | NYSE | |||
| 42.67 | 42.85 | 42.42 | -0.84 | -1.94% | 1.36M | NYSE | |||
| 1.07 | 1.09 | 1.05 | -0.0300 | -2.73% | 67.39K | NYSE | |||
| 93.98 | 94.28 | 92.38 | -0.79 | -0.83% | 6.20M | NYSE | |||
| 80.94 | 80.94 | 79.70 | -0.31 | -0.39% | 567.72K | NYSE | |||
| 4.06 | 6.42 | 2.26 | +2.000 | +97.09% | 4.12M | NASDAQ | |||
| 250.14 | 251.99 | 247.52 | +0.84 | +0.34% | 2.36M | NASDAQ | |||
| 4.44 | 4.47 | 4.44 | 0.000 | 0.00% | 0.00 | NYSE |
- Dec 30, 2021, 07:07Riped for the correction. let's watch next few weeks.
- Jul 19, 2021, 22:57Life Clips, Inc has skyrocketed roughly 3061% over the last two days after it announced a pivot into blockchain.
- Jul 19, 2021, 18:3110 dollar jump today now $29.35 from $20.
- Jul 19, 2021, 22:55Yeah I saw it
- Jul 19, 2021, 22:56Life Clips, Inc has skyrocketed roughly 3061% over the last two days after it announced a pivot into blockchain.
- Nov 11, 2020, 21:5120 soon.
- Oct 15, 2020, 19:19Is it worth continuing with this stock?
- Oct 09, 2020, 01:33Soon it will be reaching 3 months moving average $20+
- Oct 08, 2020, 18:33Different than other biopharma companies, they have a large portfolio. Bad news for short, an opportunity for long.
- Oct 08, 2020, 18:49I think there will be a bounce in the next days but do you think it's gonna go down more?
- Oct 08, 2020, 18:18sure if they can make some positive progress in their trials moving forward
- Oct 08, 2020, 18:18sure if they can make some positive progress in their trials moving forward
- Oct 08, 2020, 17:44Will this pop back up?